UK moves ahead with sweeping veterinary pricing reforms

UK regulators are moving ahead with the biggest overhaul of the country’s veterinary sector in decades, after the Competition and Markets Authority, or CMA, concluded its market investigation on March 24, 2026. The final package includes legally binding requirements for practices to publish comprehensive price lists, disclose whether they’re part of a corporate group, provide written estimates for non-emergency treatment expected to cost £500 or more, cap written prescription fees at £21 for the first medicine and £12.50 for additional medicines, and give pet parents clearer information on pet care plans and cremation options. The reforms will begin taking effect later in 2026, with some changes expected at corporate-group practices before Christmas, while the UK government is separately consulting on broader modernization of the Veterinary Surgeons Act 1966. (gov.uk)

Why it matters: For veterinary professionals, this is more than a consumer-pricing story. The CMA is explicitly tying affordability concerns to market structure, transparency, and business oversight, and it plans for the Royal College of Veterinary Surgeons to help monitor compliance and run a comparison service funded by a levy on veterinary businesses. That raises practical questions around workflow, website updates, estimate and billing processes, prescription handling, complaints procedures, and how smaller practices absorb new administrative costs. At the same time, the reforms are designed to protect clinical independence from commercial pressure, and sector groups including PDSA, RCVS, and consumer advocates have broadly welcomed the direction of travel, even as some call for stronger complaint redress and careful implementation. (gov.uk)

What to watch: The next phase is implementation: the CMA says remedies start later in 2026, while Defra’s consultation on Veterinary Surgeons Act reform will shape longer-term licensing and oversight of veterinary businesses. (gov.uk)